CTNNBL1 and asthma: Pre-administration with HP-NAP increased the levels of Th1 cytokine, IFN-γ, and the regulatory T cell (Treg) cytokine, IL-10, in BAL fluids and reduced the levels of Th2 cytokines, including IL-4 and IL-13, in BAL fluids, the level of IgE in serum, and the degree of eosinophils infiltration to the airway submucosa, indicating that HP-NAP prevents the development of asthma induced by OVA in mice [68].